Factors Associated With Provision of Addiction Treatment Information by Community Pharmacists

Hagemeier, Nicholas E.; Alamian, Arsham; Murawski, Matthew M.; Pack, Robert P.

doi:10.1016/j.jsat.2014.11.006

Cited by 28 publications

(14 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmacists are involved in numerous care activities related to the overdose crisis including screening and referral to specialized treatment, patient, community, and provider education, harm reduction provisions such as sterile syringe provision and naloxone dispensing, medication recommendations, and modeling positive attitudes to reduce the stigma attached to OUD. [15][16][17][18][19][20][21] Pharmacists with specialty training and certification work in fully integrated interdisciplinary care teams to design, implement, monitor, and modify evidence-based pharmacotherapy-centered OUD care plans. Some innovative pharmacist practices involve directly managing medications for opioid use disorder (MOUD) through delegated authority of state-based collaborative practice agreements.…”

Section: Introductionmentioning

confidence: 99%

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Bratberg

Smothers

Collins

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Introduction Nearly 2.5 million Americans have an opioid use disorder (OUD) related to prescription and/or illicit opioids. Pharmacists, as one of the most accessible care providers, are essential in mitigating the mortality and morbidity of the opioid overdose crisis. Pharmacists are involved in numerous care activities related to this crisis and to caring for patients with an OUD. Objective The objective of this paper was to conduct a literature review to highlight several pharmacist‐driven practices that provide a broad range of prevention, harm reduction, treatment, and recovery services to patients affected or potentially affected by the opioid crisis. Methods Articles had to meet the criteria of describing pharmacist‐led practice related to providing care to patients at risk of an opioid overdose, with an OUD, or related to opioid safety. The literature search was conducted in 2018 and utilized numerous sources including: OneSearch (EBSCOhost), PubMed, ScienceDirect, and the Journal of the American Pharmacists Association Opioid Topic Collection. Results Seven articles were chosen for inclusion in this review. These studies report on innovative programs and practices that describe the role of pharmacists in the opioid crisis. Studies demonstrate the types of involvement pharmacists have in caring for patients throughout the care continuum: actively engaged in upstream interventions aimed at preventing misuse and improve safety; screening and monitoring opioid prescribing and usage; providing access to naloxone; and, assisting in the recovery and rehabilitation process of patients with OUD, including collaboratively managing OUD with evidence‐based pharmacotherapy. Conclusion The studies included in our narrative review demonstrate how innovative programs and practices can expand the role of pharmacists throughout the entire spectrum of interventions applied to the opioid crisis by capitalizing on their existing skill sets and knowledge.

show abstract

Section: Introductionmentioning

confidence: 99%

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Bratberg

Smothers

Collins

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…These include the supply of injecting equipment and supervised methadone and buprenorphine dosing. Despite this, some challenges have been identified, with confidence and attitudes identified as potential barriers in delivering substance use treatment . Recent research in Scotland identified that, over time, attitudes towards these programmes are becoming more positive; pharmacists have demonstrated a willingness to receive further training which, in turn, appears to increase participation in harm‐reduction activities .…”

Section: Introductionmentioning

confidence: 99%

Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal

et al. 2016

View full text Add to dashboard Cite

show abstract

“…However, research exploring provider communication behaviors specific to prescription drug abuse is limited. 20–22 To better understand behavioral engagement in prescription drug abuse-related communication, the research team performed five focus groups with prescribers and pharmacists in South Central Appalachia who were actively engaged in POA prescribing and dispensing. One goal of the focus groups was to inform adaptation of McCroskey et al’s trait-level communication apprehension, 23 self-perceived communication competence, 24 and willingness to communicate 25 assessments to situational prescription drug abuse-specific communication and evaluate behavioral engagement across multiple situations (see details below).…”

Section: Introductionmentioning

confidence: 99%

Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors

Hagemeier

Tudiver

Brewster

et al. 2016

Research in Social and Administrative Pharmacy

Self Cite

View full text Add to dashboard Cite

Background Interpersonal communication is inherent in a majority of strategies seeking to engage prescriber and pharmacist health care professionals (HCPs) in the reduction and prevention of prescription drug abuse (PDA). However, research on HCP PDA communication behavioral engagement and factors that influence it is limited. Objectives This study quantitatively examined communication behaviors and trait-level communication metrics, and qualitatively described prescription drug abuse-related communication perceptions and behaviors among primary care prescribers and community pharmacists. Methods Five focus groups (N=35) were conducted within the Appalachian Research Network (AppNET), a rural primary care practice-based research network (PBRN) in South Central Appalachia between February and October, 2014. Focus groups were structured around the administration of three previously validated trait-level communication survey instruments, and one instrument developed by the investigators to gauge HCP prescription drug abuse communication engagement and perceived communication importance. Using a grounded theory approach, focus group themes were inductively derived and coded independently by study investigators. Member-checking interviews were conducted to validate derived themes. Results Respondents’ trait-level communication self-perceptions indicated low communication apprehension, high self-perceived communication competence, and average willingness to communicate as compared to instrument specific criteria and norms. Significant variation in HCP communication behavior engagement was noted specific to PDA. Two overarching themes were noted for HCP-patient communication: 1) influencers of HCP communication and prescribing/dispensing behaviors, and 2) communication behaviors. Multiple sub-themes were identified within each theme. Similarities were noted in perceptions and behaviors across both prescribers and pharmacists. Conclusions Despite the perceived importance of engaging in PDA communication, HCPs reported that prescription drug abuse communication is uncomfortable, variable, multifactorial, and often avoided. The themes that emerged from this analysis support the utility of communication science and health behavior theories to better understand and improve PDA communication behaviors of both prescribers and pharmacists, and thereby improve engagement in PDA prevention and treatment.

show abstract

Factors Associated With Provision of Addiction Treatment Information by Community Pharmacists

Cited by 28 publications

References 27 publications

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal

Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors

Contact Info

Product

Resources

About